| Long-term pain and adherence observational study for Endometriosis treatment |
Ongoing |
Duphaston |
4 |
DYDR-522-0318 |
Dr.Arab Clinic |
| Real world Assessment of Dyslipidemia patients on Inclisiran effiCacy And toLerability: The RADICAL Study |
Ongoing |
LEQVIO |
4 |
CKJX839A1S |
Dallah Hospital (Riyadh),International Medical Center (Jeddah), Armed Force Hospital (Tabuk),My Clinic (Jeddah), Mouwasat Hospital (Dammam) |
| Effect of celecoxib on postoperative narcotic use and disease severity in patients with aspirin-exacerbated respiratory disease and chronic rhinosinusitis: a randomized controlled trial |
Ongoing |
Celecoxib |
4 |
114809 |
King Khalid University Hospital (Riyadh), King Abdulaziz University Hospital (Riyadh) |
| EASi-HF - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral BI 690517 and empagliflozin compared with placebo and empagliflozin in participants with symptomatic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) >40% |
Ongoing |
BI 690517 , empagliflozin |
3 |
1378-0020 |
King Fahad Medical City (Riyadh), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh),King Abdulaziz Medical City NG (Riyadh), King Abdulaziz University Hospital (Jeddah) |
| Effect of Probiotics “Psychobiotics” on Depression in Adults with Obesity and Metabolic Syndrome in Riyadh City |
Ongoing |
Winclove’s Ecologic® Barrier probiotics |
3 |
E-23-7867 |
King Khalid University Hospital (Riyadh) |
| BalanceD-HF: A Phase III, Randomised, Double-blind Study to Evaluate the Effect of Balcinrenone/Dapagliflozin, Compared with Dapagliflozin, on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function |
Ongoing |
balcinrenone/dapagliflozin |
3 |
D6402C00012 |
King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz Medical NG (City Riyadh),King Abdulaziz Medical City NG (Jeddah),King Fahad Medical City (Riyadh) ,King Khalid University Hospital (Riyadh) |
| A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) |
Rejected |
Nipocalimab |
3 |
80202135EBF3001 |
King Faisal Specialist Hospital and Research Center (Riyadh), King Saud Medical City (Riyadh), King Fahad University Hospital (Al-Khobar) |
| REAL-WORLD, LONG-TERM DATA COLLECTION TO GAIN CLINICAL INSIGHTS INTO ROCHE OPHTHALMOLOGY PRODUCTS (VOYAGER STUDY)- COMPLETE |
Ongoing |
Vabysmo |
4 |
MR41927 |
King Abdulaziz Medical City NG (Jeddah) |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN) |
Ongoing |
Litifilimab |
3 |
230LE305 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Multicenter, Open-label, Single-arm, Phase 3 Long-Term Extension Study to Evaluate Continuous Safety and Efficacy of BIIB059 (Litifilimab) in Adult Participants with Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus with or without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST LTE) |
Ongoing |
Litifilimab |
3 |
230LE305 |
King Faisal Specialist Hospital and Research Center ,(Riyadh) King Khalid University Hospital (Riyadh) |
التعليقات والاقتراحات
لأي استفسارات أو ملاحظات حول الخدمات الحكومية، يرجى تعبئة المعلومات المطلوبة.